Sandra Urdaneta Hartmann, MD, PhD, MBA
Professor, Department of Microbiology and Immunology
Director, Center for Business and Program Development at the
Institute for Molecular Medicine and Infectious Disease
Drexel University College of Medicine, Philadelphia, PA

E-learning Approaches to Microbiology and Infectious Diseases Education

The COVID-19 pandemic has moved essentially all levels of education to some type of online platform. Regardless of one’s prior experience or training in online instruction, it wasn’t a choice. Many faculty at all levels of the educational spectrum had to learn how to teach online almost overnight; not an easy task. Looking into the future, more widespread online teaching of microbiology in higher education may become part of our “new normal”. The goal of this presentation is to share some tested tips and experiences gained through teaching science online to graduate students. These tips may also be applicable at the undergraduate level. This will be an interactive, live presentation via Zoom. Join us to learn about: (a) effective strategies to offer a supportive, student-centered learning environment online; (b) a few useful resources for teaching microbiology online; and (c) digital game-based learning as an emerging approach for teaching infectious disease concepts.

Time: 5 – 6pm
Place: This was a virtual meeting hosted via Zoom. Watch the lecture below and download a list of online learning resources

Keynote Speaker
Matthias J. Schnell, Ph.D.
Professor and Chair
Department of Microbiology and Immunology
Sidney Kimmel Medical College, Thomas Jefferson University

The research of the Schnell lab focuses on two areas 1) the development of vaccines against emerging viral diseases and 2) viral pathogenicity. With the use of rhabdovirus-based vectors, Dr. Schnell’s group has worked to develop vaccines against emerging diseases such as Ebola virus, MERS-CoV, Zika virus, among others. Due to the recent emergence of SARS-CoV-2, the Schnell lab has begun to turn its focus on the development of a novel SARS-CoV-2 vaccine. In this seminar, Dr. Schnell will discuss his group’s ongoing vaccine development and provide insight into the use of rhabdovirus-based vectors for vaccine development

Student talks – 4:00 – 5:00 pm
Colby Stotesbury, PhD candidate, Thomas Jefferson University
Haley Majer, PhD candidate, Drexel University College of Medicine
Amanda Miller, PhD candidate, Lewis Katz School of Medicine, Temple University

Keynote Speaker – 5:00 – 6:00 pm

This month’s meeting will be held virtually via Zoom. Details for the Zoom meeting will be emailed to the members. If you are not on the email list but would like to participate, please email Vincent Tam, PhD (vincent.tam@temple.edu)

Paul Fey, Ph.D.
University of Nebraska Medical Center
Omaha, Nebraska
Link to Paul Fey’s Website

“Clinical Microbiology in the Times of COVID-19”

This presentation will focus on the process involved in test development for SARS CoV-2.  Discussion will include some of the unforeseen challenges that we continue to experience during this pandemic.  Further discussions will involve how one might enter a career in clinical microbiology and how you can create an infrastructure to perform both basic science research and clinical microbiology at an academic medical center.

Due to public health concerns, the lecture was conducted live via Zoom.

777th Monthly Meeting
Clinical Microbiology in the Times of COVID19

Colon Cancer and “Bug” Impacts: Microbes and Communities

Cynthia L. Sears, MD
Professor of Medicine
Johns Hopkins University School of Medicine
Link to the Sears Laboratory

Colon cancer is a cancer that equally impacts men and women and is rising in incidence in younger individuals and around the globe.  Intense investigations are seeking to identify which microbes and communities may contribute to colon cancer initiation and progression. This talk will summarize aspects of the evidence base, the areas of controversy and provide some insight into experimental data that may provide guidance for development of new prevention and therapeutic strategies for colon cancer.